Evidence map›Paper›PMID 37341756›Full record

ArticleImmunoHorizons2023

Retinoic Acid Signaling Is Required for Dendritic Cell Maturation and the Induction of T Cell Immunity.

Mohammad Farazuddin, Nicholas Ludka, Leon Friesen, Jeffrey J Landers, Jessica J O'Konek, Chang H Kim, James R Baker

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mohammad FarazuddinDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-9763-6544
Nicholas LudkaMichigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0003-0410-7617
Leon FriesenDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0003-0250-7668
Jeffrey J LandersMichigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI.
Jessica J O'KonekDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-1455-0586
Chang H KimDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0003-4618-9139
James R BakerDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.
University of Michigan · US

Funding

Homing of Functionally Distinct ILC SubsetsR01AI121302 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CHANG H · 2016 to 2020
$1.9M
Mobilization and trafficking of central ILC progenitorsR01AI173179 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHANG H KIM · 2023 to 2026
$1.7M
Regulation of the development of dendritic cells in barrier tissues by retinoid gradientsR21AI148898 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CHANG H · 2020 to 2021
$414k
NIAID NIH HHS R01 AI121302NIAID NIH HHS R01 AI173179NIAID NIH HHS R21 AI148898
6 · The paper itself

Abstract

Vitamin A and its biologically active metabolites, all-trans and 9-cis retinoic acid (RA), are thought to be important in generating and modulating immune function. However, RA modulates the function of many types of immune cells, and its specific role in dendritic cell (DC) activation, Ag presentation, and T cell effector function has not been fully characterized. Because RA works primarily through RA receptor (RAR)α, we examined mice with a myeloid cell-specific defect in RA signaling. These transgenic mice have a CD11c-cre-driven expression of a truncated form of RARα that specifically blocks the signaling of all forms of RARs in myeloid cells. This defect results in abnormal DC function, with impaired DC maturation and activation, and reduced Ag uptake and processing. These DC abnormalities were associated with a reduced ability to mount Ag-specific T cell responses to immunization despite having normally functioning T cells. In contrast, the loss of DC-specific RA signaling did not significantly alter levels of Ag-specific Abs postimmunization and resulted in an increase in bronchial IgA. Our findings indicate that RA signaling in DCs is crucial for immune activation, and its absence impairs the development of Ag-specific effector functions of T cell immunity.

Indexed as

T-LymphocytesTretinoinAnimalsCell DifferentiationDendritic CellsMiceMice, TransgenicSignal TransductionTretinoin

Identifiers

PMID37341756
PMCPMC10580129
OpenAlexW4381469934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.